| Rosemary Roswell, | |
|
1400 Sudderth Dr, Ruidoso, NM 88345-6103 | |
| (505) 257-2368 | |
| (505) 257-2141 |
| Full Name | Rosemary Roswell |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1400 Sudderth Dr, Ruidoso, New Mexico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811055916 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 3493 (New Mexico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rosemary Roswell, 1400 Sudderth Dr, Ruidoso, NM 88345-6103 Ph: (505) 257-2368 | Rosemary Roswell, 1400 Sudderth Dr, Ruidoso, NM 88345-6103 Ph: (505) 257-2368 |
News Archive
Solvay Pharmaceuticals and CV Therapeutics have announced that the U.S. Food and Drug Administration (FDA) has approved Aceon (perindopril erbumine) Tablets for the treatment of patients with stable coronary artery disease to reduce the risk of cardiovascular mortality or non-fatal myocardial infarction (MI).
Synta Pharmaceuticals Corp. and QuantumLeap Healthcare Collaborative today announced that Synta's lead drug candidate, the Hsp90 inhibitor ganetespib, has been selected for study in the I-SPY 2 TRIAL (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging And moLecular Analysis 2).
Researchers at Eindhoven University of Technology (TU/e) have for the first time made high-resolution images of the earliest stages of bone formation.
A startup created by Purdue University professors is developing a sensor that can detect dangerous mosquito-borne tropical diseases faster and at a lower cost than current methods, giving health officials time to take action before the viruses are transmitted to humans.
New investigations, initiated by research workers at CIC bioGUNE and led by Dr. Aitor Hierro, have opened possibilities for making progress in the knowledge and prediction of neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS), according to the journal of The Proceedings of the National Academy of Sciences of the United States of America.This study opens the possibility of research in humans to detect this pathology before the symptoms arise.
› Verified 2 days ago
Terri Hardeman, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1400 Sudderth Dr, Ruidoso, NM 88345 Phone: 505-257-2368 Fax: 505-257-2141 | |
Margaret Dixson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 237 Service Rd, Ruidoso, NM 88345 Phone: 575-257-2368 Fax: 575-257-2141 | |
Elizabeth Orban, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 237 Service Rd, Ruidoso, NM 88345 Phone: 575-257-2368 Fax: 575-257-2141 | |
Allison Green, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 143 El Paso Rd, Ruidoso, NM 88345 Phone: 575-257-2368 | |
Alyssa Gallegos, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 237 Service Rd, Ruidoso, NM 88345 Phone: 575-257-2368 Fax: 575-257-2141 | |
Elissa Cruz, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1400 Sudderth Dr, Ruidoso, NM 88345 Phone: 505-257-2368 Fax: 505-257-2141 | |
Susan Maynard, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1400 Sudderth Dr, Ruidoso, NM 88345 Phone: 505-257-2368 Fax: 505-257-2141 |